This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies
Control of lipid levels is one of the most effective strategies for cardiovascular (CV) event preven...
Using natural products and developing pharmaceutical drugs are emerging topics to reduce blood chole...
Cardiovascular diseases (CVDs) still remain the major cause of death worldwide; however, CVD-related...
Cardiovascular disease (CVD) remains a major cause of death worldwide, with dyslipidaemia playing a ...
Dyslipidemia, specifically elevated LDL cholesterol levels, causes atherosclerotic cardiovascular di...
Based on the recent data of the DA VINCI study, it is clear that, besides utilization of statins, th...
Atherosclerotic disease remains the leading cause of death worldwide. Much of atherosclerotic diseas...
The recent introduction of inhibitors of proprotein convertase subtilisin/kexin 9 to lower low-densi...
Hypercholesterolemia is a major risk factor for cardiovascular disease (CVD). Lowering low-density l...
The diagnosis of dyslipidemia is increasing both in adulthood and in childhood because of not only t...
Hypercholesterolemia is a major risk factor for cardiovascular diseases. Serum cholesterol concentra...
Dyslipidemia refers to a broad spectrum of various genetic and acquired disorders that affect blood ...
Dyslipidemia has been globally recognized, for almost seven decades, as one of the most important ri...
Given the high incidence of cardiovascular events in the United States, strict control of modifiable...
Published online: August 29, 2014The pathogenesis and progression of atherosclerosis are integrally ...
Control of lipid levels is one of the most effective strategies for cardiovascular (CV) event preven...
Using natural products and developing pharmaceutical drugs are emerging topics to reduce blood chole...
Cardiovascular diseases (CVDs) still remain the major cause of death worldwide; however, CVD-related...
Cardiovascular disease (CVD) remains a major cause of death worldwide, with dyslipidaemia playing a ...
Dyslipidemia, specifically elevated LDL cholesterol levels, causes atherosclerotic cardiovascular di...
Based on the recent data of the DA VINCI study, it is clear that, besides utilization of statins, th...
Atherosclerotic disease remains the leading cause of death worldwide. Much of atherosclerotic diseas...
The recent introduction of inhibitors of proprotein convertase subtilisin/kexin 9 to lower low-densi...
Hypercholesterolemia is a major risk factor for cardiovascular disease (CVD). Lowering low-density l...
The diagnosis of dyslipidemia is increasing both in adulthood and in childhood because of not only t...
Hypercholesterolemia is a major risk factor for cardiovascular diseases. Serum cholesterol concentra...
Dyslipidemia refers to a broad spectrum of various genetic and acquired disorders that affect blood ...
Dyslipidemia has been globally recognized, for almost seven decades, as one of the most important ri...
Given the high incidence of cardiovascular events in the United States, strict control of modifiable...
Published online: August 29, 2014The pathogenesis and progression of atherosclerosis are integrally ...
Control of lipid levels is one of the most effective strategies for cardiovascular (CV) event preven...
Using natural products and developing pharmaceutical drugs are emerging topics to reduce blood chole...
Cardiovascular diseases (CVDs) still remain the major cause of death worldwide; however, CVD-related...
DOI
Add to ORKG